We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Painkiller Maker Seeks Review Of Obviousness Inquiry In Patent Case

(September 15, 2016, 3:24 PM EDT) -- WASHINGTON, D.C. — Following an appellate court’s decision that four patents covering the pain-relieving drug OxyContin are invalid, a painkiller manufacturer in a Sept. 1 petition for writ of certiorari asks...
To view the full article, register now.